Certain strains of Escherichia coli can cause an invasive diarrheal disease in humans which clinically resembles shigellosis. These strains share with Shigella species the ability to enter and replicate within colonic epithelial cells and the ability to bind Congo red dye in vitro when grown at 37°C. Like shigellae, they contain a large plasmid essential for virulence. A 230-kilobase (kb) plasmid from enteroinvasive E. coli was genetically malrked with a transposon and mobilized into an E. coli K-12 background. This plasmid conferred upon E. coli K-12 the ability to enter and multiply within cultured epithelial cells, as well as the ability to bind Congo red. Expiession of these phenotypes required growth at 37°C. (12, 20) . This latter phenotype has proven useful as a marker for virulence in other Shigella species, as well as in EIEC. Both of these phenotypes, cell invasion and the ability to bind Congo red dye, require growth at 37°C for their expression (11).
Enteroinvasive Escherichia coli (EIEC) comprise a group of organisms known to cause a dysenteric enteritis in humans similar to that caused by Shigella species. Experiments with both chimpanzees and human volunteers conducted by Dupont et al. (5) demonstrated that EIEC have the capacity to invade bowel tissue, multiply intracellularly, and produce a disease indistinguishable from shigellosis. As in shigellosis, the infection is localized-organisms are not found beyond the lamina propria or in the bloodstream (6) . In contrast to Shigella spp., however, a large inoculum of EIEC is required to produce disease. Whereas 200 Shigella organisms are capable of producing dysentery, over 108 EIEC are required to produce disease (5) . Thus, although it may be expected that the genetics of virulence in EIEC is similar to that of Shigella spp., one might expect to find differences as well.
EIEC share a number of biochemical characteristics with Shigella spp. They are lysine decarboxylase negative and usually nonmotile and often lack the ability to ferment lactose (21) . Dysentery-producing isolates occur within a circumscribed group of serotypes, which includes 028a and c, 029, Q42, 0112a and c, 0124, 0136, 0143, 0144, and 0152 (16, 17) . There is recent evidence that other serotypes include EIEC as well (25) . It is of interest that many of these serotypes are cross-reactive with Shigella serotypes (16) .
At present, there exist no simple biochemical methods for identifying EIEC. Like Shigella spp., they have the ability to invade guinea pig conjunctiva (Sereny test) and to invade a variety of cultured epithelial cell lines. These diagnostic tests are beyond the capability of most clinical laboratories. Because of this, little is known about the epidemiology of EIEC. More recently, DNA probes have been constructed which have shown diagnostic promise (2, 22) .
Like Shigella species, virulent EIEC contain a large plasmid (200 to 250 kilobases [kb]) whose presence has been correlated with ability to produce disease (8) . Phenotypes so far known to be plasmid encoded in S. flexneri include the ability to enter and multiply within epithelial cells (19) and the ability to bind Congo red dye (12, 20) . This latter phenotype has proven useful as a marker for virulence in other Shigella species, as well as in EIEC. Both of these phenotypes, cell invasion and the ability to bind Congo red dye, require growth at 37°C for their expression (11) .
Several lines of evidence suggest that the EIEC virulence plasmid is closely related to that of Shigella spp. Transfer of the virulence plasmid from S. flexneri to a plasmid-cured avirulent derivative of EIEC restores the ability of these bacteria to invade epithelial cells (18) . Thus, the large plasmids in EIEC and S. flexneri appear to be functionally equivalent. Hale et al. have shown that the S. flexneri plasmid exhibits considerable DNA homology with large virulence plasmids in S. sonnei and EIEC and that both produce several plasmid-encoded proteins of similar sizes (7) . Despite these similarities, restriction digests of the Shigella-EIEC group of virulence plasmids have shown few similarities (7) . Questions of whether this restriction heterogeneity reflects differences within or outside of virulence genes or differences in gene order cannot be answered until further analysis of plasmid-mediated virulence determinants has been undertaken.
In a previous paper, we have described the construction of a K-12 derivative from a clinical EIEC strain. This derivative, HB101(pSF204), contains the virulence plasmid from EIEC and expresses the invasive phenotype of the parental strain (22) pltes, on minimal medium supplemented with thiamine (1 ,ug/ml) and 0.2% glucose, or in brain heart infusion broth. Antibiotics were added in the following concentrations: ampicillin, 100 ,ug/ml; kanamycin, 20 pug/ml; chloramphenicol, 20 ,ug/ml; tetracycline, 20 ,ug/ml. Plates for scoring Congo red dye-binding ability were made from Trypticase soy agar supplemented with 0.003% Congo red dye as previously described (12) .
Construction of HB101 derivatives. A 230-kb plasmid from a clinical isolate of EIEC, E. coli 11 (0:124), was genetically marked with the ampicillin resistance transposon Tn801 by using plasmid pMR5 (13) . This is a conjugative plasmid derivative of RP1 which is temperature sensitive for replication and carries a transposon for ampicillin resistance, as well as resistance to kanamycin and tetracycline. Plate matings between HB101(pMR5) and EIEC 11 were conducted at 30°C. Transconjugants were isolated on minimal medium containing appropriate antibiotics and purified. Purified colonies were grown at 37°C for 8 h and serially diluted 1:10 every hour. After this period, dilutions were plated on Trypticase soy agar plates containing ampicillin, and transposition events were identified by replica plating of ampicillin-resistant colonies to plates containing ampicillin and kanamycin. Isolates which were ampicillin resistant and kanamycin sensitive were examined by plasmid digestion and electrophoresis to confirm insertion of the ampicillin transposon into the virulence plasmid and to confirm the loss of pMR5. The virulence plasmid containing transposon Tn801 was then mobilized into E. coli K-12 HB101 by using F'lac ts:TnJO (3) . The mobilizing plasmid was lost at a high frequency when the strain was grown at 37°C in the absence of tetracycline. One derivative, HB101(pSF204), was used for further work. Kanamycin-resistant derivatives of HB101 (pSF204) were obtained by infection of HB101(pSF204) with lambda b221cl857: :TnS Oam23 Pam8O (14) . Kanamycinresistant organisms were screened for the ability to infect HEp-2 cells. Plasmid digestions were undertaken to determine the locations of Tn5 insertions.
HEp-2 invasion assay. HEp-2 cells were cultured on glass cover slips (Bellco Glass, Inc., Vineland, N.J.) placed in the bottom of 1-dram (1 fluidram is 3.696 ml) glass shell vials (American Scientific Products, McGaw Park, Ill.) or directly on the bottom of glass vials as previously described (23) . Infected monolayers were incubated for 2 h in 5% CO2 at 37°C. The monolayers were washed three times with phosphate-buffered saline (pH 7.4), and fresh RPMI 1640 containing gentamicin (100 ug/ml) was added to kill extracellular bacteria. After 2 h, the monolayers were washed six times with phosphate-buffered saline and flooded with 1% Triton X-100 for 5 min to release intracellular bacteria. The lysed monolayers were plated, and the numbers of CFU per milliliter were determined. Cultures were made of supernatant from each well after 1 h of incubation in the presence of gentamicin to ensure that there was no survival of extracellular bacteria (data not shown). Experiments were run in triplicate and repeated at least five times per isolate.
Temperature dependence. Duplicate cultures of isolates to be tested were grown overnight at 30 and 37°C. On the following morning, tubes containing brain heart infusion broth were inoculated with these cultures and grown for an additional 2 h with shaking at 30 and 37°C. HEp-2 monolayers were infected for 2 h as described above, and incubation was continued for an additional 2 h in the presence of fresh RPMI 1640 containing gentamicin (100 ,ug/ml). Infected monolayers were washed, lysed, and plated to determine numbers of bacteria which had survived gentamicin killing. Experiments were done in triplicate and repeated at least five times per isolate.
Congo red dye-binding ability. Isolates to be tested were spread on Trypticase soy agar plates containing 0.003% Congo red dye and grown for 24 to 30 h at 37°C. Congo red-positive (CR+) isolates appeared orange-red after this period of time, whereas Congo red-negative (CR-) isolates had a pale orange tint.
Isolation of noninvasive mutants by TnS mutagenesis. HB101, containing virulence plasmid pSF204 from EIEC 11, was infected with a lambda derivative, b221 c1l857::TnS Oam8 Pam29 (14) . Mutations induced by transposition of Tn5 to the 230-kb virulence plasmid pSF204 were isolated in the following manner. Dilutions of HB101(pSF204) infected with lambda b221 cI1857: :TnS were plated on Trypticase soy agar containing 20 ,ug of kanamycin per ml and 0.003% Congo red dye. All CR-colonies and several CR+ colonies were purified, screened for the ability to invade HEp-2 cells, and examined for plasmid content. Insertions into the virulence plasmid were also identified by mobilization of pSF204::TnS from HB101 into a noninvasive S. flexneri strain (25-8A) lacking the S. flexneri virulence plasmid (19) . Transconjugants were screened for the invasiveness and Congo red dye-binding phenotypes and analyzed for plasmid content.
Plasmid isolation and electrophoresis. Plasmid DNA was prepared by the method of Birnboim and Doly (1) and purified through CsCI-ethidium bromide density gradient centrifugation. DNA was electrophoresed in horizontal 0.6% agarose gels in Tris-acetate buffer (9) .
Restriction endonuclease digestion. DNA was digested by restriction endonucleases in a final volume of 20 RI under appropriate conditions (9) . Each reaction mixture contained 
RESULTS
TnS mutagenesis. Using TnS transposon mutagenesis, we obtained 1.3 x 104 colonies of kanamycin-resistant HB101 (pSF204) derivatives. Since pSF204 was too large to transform, we used the Congo red-binding phenotype to identify insertions in plasmid DNA. Fourteen CR-colonies were identified and purified. When assayed for the ability to enter HEp-2 cells, all 14 of these CR-mutants had lost this ability. Analysis of plasmid DNAs from these derivatives digested with BamHI showed that Tn5 had been transposed onto pSF204. Five CR+ isolates were also assayed for the ability to enter HEp-2 cells, and all five had retained this ability. We also examined the invasiveness and Congo red-binding phenotypes of 19 insertional mutants isolated by mobilization of pSF204::Tn5 into S. flexneri M25-8A (19), a noninvasive strain lacking the virulence plasmid. Successful mobilization of the kanamycin marker was interpreted as evidence that TnS insertions had occurred in the plasmid. Investigation of these 19 isolates revealed that 15 were CR-and noninvasive and 4 were CR+ and invasive. These results demonstrated that pSF204 expressed the Congo red dye-binding and invasiveness phenotypes in both an EIEC and an S. flexneri background and that in each case there was a correlation between the presence of the plasmid and the abilities to invade epithelial cells and bind Congo red.
Mapping virulence regions in pSF204. Plasmid analysis of 14 CR-, noninvasive TnS mutants (in HB101) revealed that in three cases deletion or inversion of pSF204 DNA had occurred along with transposition. These mutants were not analyzed further. Probing the remaining 11 insertional mutants with TnS, we found eight independent insertions. These mapped to a single 25-kb BamHI fragment flanked by a 31-kb BamHI fragment to the left and a 26-kb BamHI fragment to the right (Fig. 1) . With DNA cloned from the left end of the 25-kb BamHI fragment as a probe, TnS insertions were mapped along this fragment. The locations of these insertions are shown in Fig. 1 . It can be seen that one group of TnS insertions is clustered to the left end of the fragment, separated by about 10 kb from insertions in the right half of the fragment. Insertions in the right portion of the 25-kb fragment are less tightly clustered than those in the left.
Cloning and complementation of the invasiveness phenotype. In an attempt to define virulence regions covered by the Tn5 insertions further, we made subclones from the right and left regions of the 25-kb BamHI fragment. One clone, pPS15, contained a 15-kb ClaI fragment which covered 8 kb from the left end of the 25-kb BamHI fragment and extended 7 kb into the adjacent 31-kb BamHI fragment. We also derived several classes of deletion mutants by digesting and religating pPS15 with PstI and BamHI. One of these, pRJ6, contained a 6-kb fragment internal to the left end of the 25-kb BamHI fragment. A ClaI fragment containing 7 kb from the right end of the 25-kb fragment was cloned into pBR325 (pPS7). The relationships of these cloned fragments to the TnS insertions in the 25-kb virulence-associated BamHI fragment are shown in Fig. 1 .
Deletion derivatives of pPS15, as well as pPS15, were transformed into 11 derivatives of HB101(pSF204) containing single TnS insertions. The resulting strains were assayed for the ability to complement the invasiveness phenotype. A clone encompassing 7 kb from the right end of the 25-kb BamHI fragment, pPS7, was also assayed for ability to complement insertions in the 25-kb BamHI fragment. Results of these experiments are shown in Table 1 . When transformed into noninvasive mutants containing insertions within the left half of the 25-kb BamHI fragment, pPS15 was able to restore to noninvasive mutants the ability to enter and replicate within epithelial cells ( Table 2) . Expression of this invasiveness phenotype, as well as expression of the Congo red-binding phenotype, required growth at 37°C (Table 2) . A deletion derivative, pRJ6, complemented all but one insertion in the left half of the 25-kb plasmid (Table 1) . Only the most leftward insertion was not complemented. Although complementation in trans of invasion was complete, complementation of the Congo red-binding phenotype was only partially restored, as indicated by a less intense reddish color found in complemented isolates as compared with the parental strain. We were unable to complement any insertions in the 25-kb BamHI fragment with pPS7 for either invasiveness or Congo red binding.
DISCUSSION
The ability of certain bacterial pathogens to enter and survive within host epithelial cells has been the focus of much current research. Work from several laboratories indicates that several plasmid-mediated determinants appear to be necessary for expression of the invasiveness pheno- type in Shigella spp. (10, 15, 20 Complementation data provide evidence that at least one soluble gene product required for invasion can complement noninvasive TnS mutants. Although pPS15 complemented the invasiveness phenotype completely, the Congo redbinding phenotype was only partially restored. In S. flexneri, it appears that more than one Congo red-binding determinant is found on the virulence plasmid (15) . This may be true in EIEC as well. We were disappointed that pPS7 failed to complement insertions in the right half of the 25-kb BamHI fragment and are in the process of cloning larger fragments from that portion of the plasmid to determine whether the failure to get complementation was because we had interrupted a gene during cloning or because insertions in this area cannot be complemented in trans.
The invasiveness phenotype in EIEC, as in Shigella spp., involves both the ability to enter the host cell and the ability to escape from an endocytic vacuole and gain access to the cytoplasm, where rapid multiplication takes place. It is reasonable to hypothesize that the ability to enter a host cell and the ability to escape from the endocytic vacuole are encoded by separate loci. We have no evidence to support this, however. In fact, we were unable to obtain a mutant which retained the ability to enter a host cell and yet was incapable of intracellular multiplication. It is possible that EIEC enter the host cell and gain access to the cytoplasm by the same mechanism.
How Shigella spp. and EIEC gain entrance to nonprofessional phagocytes such as epithelial cells is of great interest. One possibility is that the bacteria carry on the surface a biochemical structure which is recognized by a specific eucaryotic cell receptor and that recognition of this structure sets in motion a series of events leading to endocytosis. Compared with Shigella spp., EIEC are less efficient in their invasion of epithelial cells. This may be due to differences in outer membrane proteins.
Further mapping of virulence-associated regions and identification of the gene products of these regions are necessary before basic questions regarding the bacterium-host cell interactions involved in pathogenesis can be answered.
